Richard L Carpenter
Overview
Explore the profile of Richard L Carpenter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
1364
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li C, Xie Q, Ghosh S, Cao B, Du Y, Vo G, et al.
JCI Insight
. 2025 Mar;
10(5).
PMID: 40059829
Glioblastoma (GBM) is the most lethal brain cancer, with GBM stem cells (GSCs) driving therapeutic resistance and recurrence. Targeting GSCs offers a promising strategy for preventing tumor relapse and improving...
2.
Williams I, OMalley M, DeHart H, Walker B, Ulhaskumar V, Jothirajah P, et al.
Cancer Res Commun
. 2025 Jan;
5(2):253-266.
PMID: 39831777
We show that HSF1 and MYC genes are co-amplified in more than 30% of HGSOC and demonstrate that HSF1 and MYC functionally cooperate to drive the growth of HGSOC cells....
3.
Rimkus T, Carpenter R, Sirkisoon S, Zhu D, Pasche B, Chan M, et al.
Cancer Res
. 2024 Oct;
84(19):3310.
PMID: 39350666
No abstract available.
4.
Blackman A, Rees A, Bowers R, Jones C, Vaena S, Clark M, et al.
Cancer Res Commun
. 2024 Sep;
4(9):2525-2538.
PMID: 39225558
Significance: Mouse models using transgenes which generate spontaneous cancers are essential tools to examine the etiology of human diseases. Here, the first Myc-driven spontaneous model is described as a valid...
5.
Williams I, DeHart H, OMalley M, Walker B, Ulhaskumar V, Ray H, et al.
bioRxiv
. 2024 Jun;
PMID: 38915574
Ovarian cancer is a deadly female cancer with high rates of recurrence. The primary treatment strategy for patients is platinum-based therapy regimens that almost universally develop resistance. Consequently, new therapeutic...
6.
Sirkisoon S, Carpenter R, Rimkus T, Anderson A, Harrison A, Lange A, et al.
Oncogene
. 2024 Jun;
43(30):2371.
PMID: 38867080
No abstract available.
7.
Doheny D, Sirkisoon S, Carpenter R, Aguayo N, Regua A, Anguelov M, et al.
Oncogene
. 2024 Apr;
43(23):1811.
PMID: 38678124
No abstract available.
8.
Buchner J, Alasady M, Backe S, Blagg B, Carpenter R, Colombo G, et al.
Cell Stress Chaperones
. 2024 Feb;
29(1):88-96.
PMID: 38316354
No abstract available.
9.
Smith J, Husted S, Pilrose J, Ems-McClung S, Stout J, Carpenter R, et al.
Cancers (Basel)
. 2024 Jan;
16(2).
PMID: 38254909
The authors alerted the Editorial Office of the mistake on 5 August 2023 and the final documents were sent for evaluation on 12 December 2023 [...].
10.
Young T, Kappler M, Hockaden N, Carpenter R, Jacobson S
Anal Chem
. 2023 Nov;
95(45):16710-16716.
PMID: 37916500
Extracellular vesicles (EVs) are cell-derived, naturally produced, membrane-bound nanoscale particles that are linked to cell-cell communication and the propagation of diseases. Here, we report the design and testing of in-plane...